High prevalence and high incidence of coinfection with Hepatitis B, Hepatitis C, and syphilis and low rate of effective vaccination against Hepatitis B in HIVPositive men who have sex with men with known date of HIV seroconversion in Germany

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Jansen, Klaus ^a   Thamm, Michael ^a   Bock, Claus Thomas ^a   Scheufele, Ramona ^a   Kücherer, Claudia ^a   Muenstermann, Dieter ^b   Hagedorn, Hans Jochen ^b   Jessen, Heiko ^c   Dupke, Stephan ^d   Hamouda, Osamah ^a   Gunsenheimer Bartmeyer, Barbara ^a   Meixenberger, Karolin ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b Labor Krone   (Germany)

^c Medical Care Centre Jessen   (Germany)

^d Medical Care Centre Driesener Strasse   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ADOLESCENT; AGE DISTRIBUTION; AGED; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; GERMANY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; MIXED INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; SEROCONVERSION; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; ADULT; COMPLICATION; HIV INFECTIONS; INCIDENCE; MALE HOMOSEXUALITY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; GERMANY; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS C; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; SEROCONVERSION; SYPHILIS; YOUNG ADULT;

EID: 84953807111     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142515     Document Type: Article

References (93)

1. Bernstein KT, Marcus JL, Nieri G, Philip SS, Klausner JD. Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion. J Acquir Immune DeficSyndr. 2010; 53 (4):537-43. doi: 10.1097/QAI.0b013e3181 c3ef29 PMID: 19935075
2. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006; 20(1):73-83. PMID: 16327322
3. Jin F, Prestage GP, Imrie J, Kippax SC, Donovan B, Templeton DJ, et al. Anal sexually transmitted infections and risk of HIV infection in homosexual men. J Acquir Immune DeficSyndr. 2010; 53(1):144-9. doi: 10.1097/QAI.0b013e3181b48f33 PMID: 19734801
4. Buchacz K, Patel P, Taylor M, Kerndt PR, Byers RH, Holmberg SD, et al. Syphilis increases HIV viral load and decreases CD4cell counts in HIV-infected patients with new syphilis infections. AIDS. 2004; 18(15):2075-9. PMID: 15577629
5. de Ledinghen V, Barreiro P, Foucher J, Labarga P, Castera L, Vispo ME, et al. Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy. Journal of viral hepatitis. 2008; 15(6):427-33. doi: 10.1111/j.1365-2893.2007.00962.x PMID: 18221303
6. Sulkowski MS. Current management of hepatitis C virus infection in patients with HIV co-infection. The Journal of infectious diseases. 2013; 207Suppl 1:S26-32. doi: 10.1093/infdis/jis764 PMID: 23390302
7. Joshi D, O'Grady J, Dieterich D, Gazzard B, Agarwal K. Increasing burden of liver disease in patients with HIV infection. Lancet. 2011; 377(9772):1198-209. doi: 10.1016/S0140-6736(10)62001-6 PMID: 21459211
8. Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet. 2014; 384 (9939):241-8. doi: 10.1016/S0140-6736(14)60604-8 PMID: 25042234
9. Weber R, Ruppik M, Rickenbach M, Spoerri A, Furrer H, Battegay M, et al. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV medicine. 2013; 14(4):195-207. doi: 10.1111/j.1468-1293.2012.01051.x PMID: 22998068
10. Rockstroh JK. Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals. Liver international: official journal of the International Association for the Study of the Liver. 2015; 35Suppl 1:51-5.
11. Sulkowski MS. Management of acute and chronic HCV infection in persons with HIVcoinfection. Journal of hepatology. 2014; 61(1 Suppl):S108-19.
12. European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2013. Stockholm: European Centre for Disease Prevention and Control; 2014.
13. Robert Koch-Institut. Schätzung der Prävalenz und Inzidenzvon HIV-Infektionen in Deutschland (Stand: Ende 2013). Epidemiologisches Bulletin. 2014; 2014(44):429-37.
14. deCoul EL, Warning TD, Koedijk FD, Dutch STIc. Sexual behaviour and sexually transmitted infections in sexually transmitted infection clinic attendees in the Netherlands, 2007-2011. Int J STD AIDS. 2014; 25(1):40-51. doi: 10.1177/0956462413491736 PMID: 23970630
15. Dougan S, Evans BG, Elford J. Sexually transmitted infections in Western Europe among HIV-positive men who have sex with men. Sexually Transmitted Diseases. 2007; 34(10):783-90. PMID: 17495592
16. Heiligenberg M, Rijnders B, Schim van der Loeff MF, de Vries HJ, van derMeijden WI, Geerlings SE, et al. High prevalence of sexually transmitted infections in HIV-infected men during routine outpatient visits in the Netherlands. SexTransm Dis. 2012; 39(1):8-15. doi: 10.1097/OLQ.0b013e3182354e81 PMID: 22183837
17. Jin F, Prestage GP, Zablotska I, Rawstorne P, Kippax SC, Donovan B, et al. High rates of sexually transmitted infections in HIV positive homosexual men: data from two community based cohorts. Sex Transm Infect. 2007; 83(5):397-9. PMID: 17556503
18. Fenton KA, Lowndes CM. Recent trends in the epidemiology of sexually transmitted infections in the European Union. SexTransm Infect. 2004; 80(4):255-63. PMID: 15295121
19. Nicoll A, Hamers FF. Are trends in HIV, gonorrhoea, and syphilis worsening in western Europe? British Medical Journal. 2002; 324(7349):1324-7. PMID: 12039830
20. Torrone EA, Bertolli J, Li J, Sweeney P, Jeffries WLt, Ham DC, et al. Increased HIV and primary and secondary syphilis diagnoses among young men-United States, 2004-2008. J Acquir Immune Defic Syndr. 2011; 58(3):328-35. doi: 10.1097/QAI.0b013e31822e1075 PMID: 21826012
21. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. Journal of hepatology. 2006; 44(1 Suppl): S6-9.
22. Branger J, van der Meer JT, van Ketel RJ, Jurriaans S, Prins JM. High incidence of asymptomatic syphilis in HIV-infected MSM justifies routine screening. SexTransm Dis. 2009; 36(2):84-5. doi: 10.1097/OLQ.0b013e318186debb PMID: 18971797
23. Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, et al. Hepatitis Band HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS. 2005; 19(6):593-601. PMID: 15802978
24. Lacombe K, Rockstroh J. HIV and viral hepatitis coinfections: advances and challenges. Gut. 2012; 61 Suppl 1:i47-58. doi: 10.1136/gutjnl-2012-302062 PMID: 22504919
25. Marcus U, Kollan C, Bremer V, Hamouda O. Relation between the HIV and the re-emerging syphilis epidemic among MSM in Germany: an analysis based on anonymous surveillance data. Sex Transm Infect. 2005; 81(6):456-7. PMID: 16326845
26. Peterman TA, Furness BW. The resurgence of syphilis among men who have sex with men. CurrOpin Infect Dis. 2007; 20(1):54-9. PMID: 17197882
27. Soriano V, Mocroft A, Peters L, Rockstroh J, Antunes F, Kirkby N, et al. Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe. The Journal of antimicrobial chemotherapy. 2010; 65(3):548-55. doi: 10.1093/jac/dkp479 PMID: 20051475
28. Thurnheer MC, Weber R, Toutous-Trellu L, Cavassini M, Elzi L, Schmid P, et al. Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV Cohort Study. AIDS. 2010; 24(12):1907-16. doi: 10.1097/QAD.0b013e32833bfe21 PMID: 20616699
29. European AIDS clinical society. EACS guidelines 7.02. Brussels: European AIDS clinical society; 2014.
30. Impfkommission Ständige. Impfungen für Erwachsene. Bundesgesundheitsblatt. 1983; 26(5):130-2.
31. Cruciani M, Mengoli C, Serpelloni G, Lanza A, Gomma M, Nardi S, et al. Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients. Vaccine. 2009; 27(1):17-22. doi: 10.1016/j.vaccine.2008.10.040 PMID: 18984022
32. de Vries-Sluijs TE, Hansen BE, van Doornum GJ, Kauffmann RH, Leyten EM, Mudrikova T, et al. A randomized controlled study of accelerated versus standard hepatitis B vaccination in HIV-positive patients. The Journal of infectious diseases. 2011; 203(7):984-91. doi: 10.1093/infdis/jiq137 PMID: 21266513
33. Landrum ML, Huppler Hullsiek K, Ganesan A, Weintrob AC, Crum-Cianflone NF, Barthel RV, et al. Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count. Vaccine. 2009; 27(34):4731-8. doi: 10.1016/j.vaccine. 2009.04.016 PMID: 19540026
34. Lopes VB, Hassing RJ, de Vries-Sluijs TE, El Barzouhi A, Hansen BE, Schutten M, et al. Long-term response rates of successful hepatitis B vaccination in HIV-infected patients. Vaccine. 2013; 31 (7):1040-4. doi: 10.1016/j.vaccine.2012.12.047 PMID: 23273969
35. van den Berg R, van Hoogstraten I, van Agtmael M. Non-responsiveness to hepatitis B vaccination in HIV seropositive patients; possible causes and solutions. AIDS reviews. 2009; 11(3):157-64. PMID: 19654857
36. Yao ZQ, Moorman JP. Immune exhaustion and immune senescence: two distinct pathways for HBV vaccine failure during HCV and/or HIV infection. Archivum immunologiae ettherapiae experimentalis. 2013; 61(3):193-201. doi: 10.1007/s00005-013-0219-0 PMID: 23400275
37. Chadwick D, Doyle T, Ellis S, Price D, Abbas I, Valappil M, et al. Occult hepatitis B virus coinfection in HIV-positive African migrants to the UK: a point prevalence study. HIV medicine. 2014; 15(3):189-92. doi: 10.1111/hiv.12093 PMID: 24118868
38. Khamduang W, Ngo-Giang-Huong N, Gaudy-Graffin C, Jourdain G, Suwankornsakul W, Jarupanich T, et al. Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2013; 56(12):1704-12.
39. Liang SH, Chen TJ, Lee SS, Tseng FC, Huang CK, Lai CH, et al. Risk factors of isolated antibody against core antigen of hepatitis B virus: association with HIV infection and age but not hepatitis C virus infection. J Acquir Immune DeficSyndr. 2010; 54(2):122-8. doi: 10.1097/QAI.0b013e3181daafd5 PMID: 20386111
40. Morsica G, Ancarani F, Bagaglio S, Maracci M, Cicconi P, Cozzi Lepri A, et al. Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features. Infection. 2009; 37(5):445-9. doi: 10.1007/s15010-008-8194-9 PMID: 19669092
41. Taylor LE, Swan T, Matthews GV. Management of hepatitis C virus/HIV coinfection among people who use drugs in the era of direct-acting antiviral-based therapy. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2013; 57 Suppl 2:S118-24.
42. Walsh N, Maher L. HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment. Current opinion in HIV and AIDS. 2012; 7(4):339-44. doi: 10.1097/COH.0b013e328354131e PMID: 22498482
43. Ingiliz P, Krznaric I, Stellbrink HJ, Knecht G, Lutz T, Noah C, et al. Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleu-kin-28B genotype on spontaneous clearance. HIV medicine. 2014; 15(6):355-61. doi: 10.1111/hiv. 12127 PMID: 24580777
44. Obermeier M, Ingiliz P, Weitner L, Cordes C, Moll A, Hintsche B, et al. Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): the "real-life setting" proves the concept. European journal of medical research. 2011; 16(5):237-42. PMID: 21719398
45. Sanchez C, Plaza Z, Vispo E, de Mendoza C, Barreiro P, Fernandez-Montero JV, et al. Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain. Liver international: official journal of the International Association forthe Study of the Liver. 2013; 33 (9):1357-62.
46. Urbanus AT, Van De Laar TJ, Geskus R, Vanhommerig JW, Van Rooijen MS, Schinkel J, et al. Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995-2010. AIDS. 2014; 28(5):781-90. doi: 10.1097/QAD.0000000000000126 PMID: 24832014
47. Urbanus AT, van de Laar TJ, Stolte IG, Schinkel J, Heijman T, Coutinho RA, et al. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS. 2009; 23 (12):F1-7. doi: 10.1097/QAD.0b013e32832e5631 PMID: 19542864
48. van de Laar T, Pybus O, Bruisten S, Brown D, Nelson M, Bhagani S, et al. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology. 2009; 136(5):1609-17. PMID: 19422083
49. Vogel M, Deterding K, Wiegand J, Gruner NH, Baumgarten A, Jung MC, et al. Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infection. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2009; 49(2):317-9; author reply 9.
50. Apers L, Vanden Berghe W, De Wit S, Kabeya K, Callens S, Buyze J, et al. Risk factors for HCV acquisition among HIV-positive MSM in Belgium. J Acquir Immune DeficSyndr. 2015; 68(5):585-93. doi: 10. 1097/QAI.0000000000000528 PMID: 25763786
51. Danta M, Brown D, Bhagani S, Pybus OG, Sabin CA, Nelson M, et al. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS. 2007; 21(8):983-91. PMID: 17457092
52. Schmidt AJ, Rockstroh JK, Vogel M, An der Heiden M, Baillot A, Krznaric I, et al. Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany-a case-control study. PLoSOne. 2011; 6(3):e17781. doi: 10.1371/journal.pone.0017781 PMID: 21408083
53. Tohme RA, Holmberg SD. Is sexual contact a major mode of hepatitis C virus transmission? Hepatol-ogy. 2010; 52(4):1497-505. doi: 10.1002/hep.23808 PMID: 20635398
54. van de Laar TJ, Matthews GV, Prins M, Danta M. Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection. AIDS. 2010; 24(12):1799-812. doi: 10.1097/QAD.0b013e32833c11a5 PMID: 20601854
55. Wong J, Moore D, Kanters S, Buxton J, Robert W, Gustafson R, et al. Seroprevalence of hepatitis C and correlates of seropositivity among men who have sex with men in Vancouver, Canada: a cross-sectional survey. SexTransm Infect. 2015.
56. Bremer V, Marcus U, Hofmann A, Hamouda O. Building a sentinel surveillance system for sexually transmitted infections in Germany, 2003. SexTransm Infect. 2005; 81(2):173-9. PMID: 15800099
57. Dudareva-Vizule S, Haar K, Sailer A, Wisplinghoff H, Wisplinghoff F, Marcus U, et al. Prevalence of pharyngeal and rectal Chlamydia trachomatis and Neisseria gonorrhoeae infections among men who have sex with men in Germany. SexTransm Infect. 2014; 90(1):46-51. doi: 10.1136/sextrans-2012-050929 PMID: 23920398
58. Hamouda O, Bremer V, Marcus U, Bartmeyer B. [Epidemiological developments of selected sexually transmitted infections in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013; 56(12):1600-8. doi: 10.1007/s00103-013-1866-3 PMID: 24337121
59. Marcus U, Bremer V, Hamouda O, Kramer M, Freiwald M, Jessen H, et al. Understanding recent increases in the incidence of sexually transmitted infections in men having sex with men: changes in risk behavior from risk avoidance to risk reduction. Sexually Transmitted Diseases. 2006; 33(1):11. PMID: 16385216
60. Schmidt AJ, Marcus U. Self-reported history of sexually transmissible infections (STIs) and STI-related utilization of the German health care system by men who have sex with men: data from a large convenience sample. BMC Infect Dis. 2011; 11:132. doi: 10.1186/1471-2334-11-132 PMID: 21592342
61. Spielmann N, Münstermann D, Hagedorn H, Heiden M, Houareau C, Gunsenheimer-Bartmeyer B, et al. Time trends of syphilis and HSV-2 co-infection among men who have sex with men in the German HIV-1 seroconverter cohort from 1996-2007. Sexually Transmitted Infections. 2010; 86(5):331. doi: 10. 1136/sti.2009.040857 PMID: 20876750
62. Spornraft-Ragaller P, Schmitt J, Stephan V, Boashie U, Besissert S. Characteristics and coinfection with syphilis in newly HIV-infected patients at the University hospital Dresden 1987-2012. Journal der Deutschen Dermatologischen Gesellschaft. 2014; 12(8):1-10.
63. Poggensee G, Kucherer C, Werning J, Somogyi S, Bieniek B, Dupke S, et al. Impact of transmission of drug-resistant HIV on the course of infection and the treatment success. Data from the German HIV-1 Seroconverter Study. HIV Med. 2007; 8(8):511-9. PMID: 17944684
64. Zu Knyphausen F, Scheufele R, Kucherer C, Jansen K, Somogyi S, Dupke S, et al. First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter study. PloSone. 2014; 9(5):e95956. doi: 10. 1371/journal.pone.0095956 PMID: 24788613
65. Bartmeyer B, Kuecherer C, Houareau C, Werning J, Keeren K, Somogyi S, et al. Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort. PloSone. 2010; 5(10):e12718. doi: 10.1371/journal.pone.0012718 PMID: 20949104
66. Hagedorn H-J. Aktuelle Aspekte zur Syphilisdiagnostik. Abbott Times. 2010; 20(2):11-7.
67. The EMIS Network. EMIS 2010: The European Men-Who-Have-Sex-With-Men Internet Survey. Findings from 38 countries. Stockholm: European Centre for Disease Prevention and Control, 2013.
68. Anderson AM, Mosunjac MB, Palmore MP, Osborn MK, Muir AJ. Development of fatal acute liver failure in HIV-HBVcoinfected patients. World J Gastroenterol. 2010; 16(32):4107-11. PMID: 20731028
69. Kim JH, Psevdos G Jr, Sharp V. Five-year review of HIV-hepatitis B virus (HBV) co-infected patients in a New York City AIDS center. J Korean Med Sci. 2012; 27(7):830-3. doi: 10.3346/jkms.2012.27.7.830 PMID: 22787385
70. O'Bryan TA, Rini EA, Okulicz J, Messner O, Ganesan A, Lalani T, et al. HIVviraemia during hepatitis B vaccination shortens the duration of protective antibody levels. HIV medicine. 2015; 16(3):161-7. doi: 10.1111/hiv.12189 PMID: 25586899
71. Rey D, Krantz V, Partisani M, Schmitt MP, Meyer P, Libbrecht E, et al. Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. Vaccine. 2000; 18(13):1161-5. PMID: 10649616
72. Maldonado-Rodriguez A, Cevallos AM, Rojas-Montes O, Enriquez-Navarro K, Alvarez-Munoz MT, Lira R. Occult hepatitis B virus co-infection in human immunodeficiency virus-positive patients: A review of prevalence, diagnosis and clinical significance. World J Hepatol. 2015; 7(2):253-60. doi: 10.4254/wjh. v7.i2.253 PMID: 25729480
73. Shire NJ, Rouster SD, Stanford SD, Blackard JT, Martin CM, Fichtenbaum CJ, et al. The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. J Acquir Immune DeficSyndr. 2007; 44(3):309-14. PMID: 17159656
74. Poethko-Müller C, Zimmermann R, Hamouda O, Faber M, Stark K, Ross RS, et al. Die Seroepidemiologie der Hepatitis A, BundC in Deutschland. Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013; 56:707-15.
75. Rauch A, Rickenbach M, Weber R, Hirschel B, Tarr PE, Bucher HC, et al. Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2005; 41(3):395-402.
76. Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, et al. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. The Journal of infectious diseases. 2005; 192(6):992-1002. PMID: 16107951
77. van der Helm JJ, Prins M, del Amo J, Bucher HC, Chene G, Dorrucci M, et al. The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007. AIDS. 2011; 25(8):1083-91. doi: 10. 1097/QAD.0b013e3283471cce PMID: 21537114
78. Gamage DG, Read TR, Bradshaw CS, Hocking JS, Howley K, Chen MY, et al. Incidence of hepatitis-C among HIV infected men who have sex with men (MSM) attending a sexual health service: a cohort study. BMC Infect Dis. 2011; 11:39. doi: 10.1186/1471-2334-11-39 PMID: 21291565
79. van de Laar TJ, van der Bij AK, Prins M, Bruisten SM, Brinkman K, Ruys TA, et al. Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. The Journal of infectious diseases. 2007; 196(2):230-8. PMID: 17570110
80. Wandeler G, Gsponer T, Bregenzer A, Gunthard HF, Clerc O, Calmy A, et al. Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2012; 55(10):1408-16.
81. Linas BP, Wong AY, Schackman BR, Kim AY, Freedberg KA. Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sexwith men. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2012; 55(2):279-90.
82. Sulkowski MS. HCV therapy in HIV-infected patients. Liver international: official journal of the International Association for the Study of the Liver. 2013; 33Suppl 1:63-7.
83. Wong W, Chaw JK, Kent CK, Klausner JD. Riskfactors for early syphilis among gay and bisexual men seen in an STD clinic: San Francisco, 2002-2003. SexTransm Dis. 2005; 32(7):458-63. PMID: 15976605
84. Zetola NM, Klausner JD. Syphilis and HIV infection: an update. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2007; 44(9):1222-8.
85. Robert Koch-Institut. Syphilis in Deutschland 2013. Epidemiologisches Bulletin. 2014; 2014(50):485-93.
86. Rieg G, Lewis RJ, Miller LG, Witt MD, Guerrero M, Daar ES. Asymptomatic sexually transmitted infections in HIV-infected men who have sex with men: prevalence, incidence, predictors, and screening strategies. AIDS patient care and STDs. 2008; 22(12):947-54. doi: 10.1089/apc.2007.0240 PMID: 19072101
87. Chamie G, Bonacini M, Bangsberg DR, Stapleton JT, Hall C, Overton ET, et al. Factors associated with seronegative chronic hepatitis C virus infection in HIV infection. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2007; 44(4):577-83.
88. Nastouli E, Thomson EC, Karayiannis P, Main J, McClure M, Muir D. Diagnosing acute hepatitis C in HIV-infected patients: nucleic acid testing compared with antibody and antigen-antibody detecting methods. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology. 2009; 44(1):78-80.
89. Thomson EC, Nastouli E, Main J, Karayiannis P, Eliahoo J, Muir D, et al. Delayedanti-HCVantibody response in HIV-positive men acutely infected with HCV. AIDS. 2009; 23(1):89-93. doi: 10.1097/QAD. 0b013e32831940a3 PMID: 19050390
90. Laboratories Abbott. Packungsbeilage zum Architect-System, Anti-HCV (G4-7756/R10). Wiesbaden: Abbott Laboratories, 2014.
91. Attar BM, Van Thiel D. A New Twist to a Chronic HCV Infection: Occult Hepatitis C. Gastroenterol Res Pract. 2015; 2015:579147. doi: 10.1155/2015/579147 PMID: 26221136
92. Filippini P, Di Martino F, Martini S, Pisaturo M, Sagnelli E, Coppola N. Absence of occult HCV infection in HIV-positive patients. The Journal of infection. 2012; 64(4):436-7. doi: 10.1016/j.jinf.2011.12.018 PMID: 22226691
93. Gatserelia L, Sharvadze L, Karchava M, Dolmazashvili E, Tsertsvadze T. Occurrence of occult HCV infection among Hiv infected patients in Georgia. Georgian Med News. 2014(226):37-41.